Sexual life and contraception in people living with HIV

1. UNAIDS/WHO. Antiretroviral therapy and sexual transmission of HIV. Geneva. 1 February 2008. www.who.int/entity/hiv/mediacentre/080201_hivtransmission_en.pdf.Search in Google Scholar

2. Andia I, Kaida A, Maier M, Guzman D, Emenyonu N, Pepper L, et al. Highly active antiretroviral therapy and increased use of contraceptives among HIVpositive women during expanding access to antiretroviral therapy in Mbarara, Uganda. Am J Public Health. 2009; 99:340-7.10.2105/AJPH.2007.129528Search in Google Scholar

3. Valverde EE, Cassetti I, Metsch LR, Bugarin G, Bofill L, Laurido M, et al. Sex risk practices among HIVpositive individuals in Buenos Aires, Argentina. AIDS Pat Care STD. 2009; 23:551-6.10.1089/apc.2008.0094Search in Google Scholar

4. World Health Organization (WHO). Reproductive choices and family planning for people living with HIV. Geneva:WHO, 2006.Search in Google Scholar

5. Myer L, Carter RJ, Katyal M, Toro P, El-Sadr WM, Abrams EJ. Impact of antiretroviral therapy on incidence of pregnancy among HIV-infected women in Sub-Saharan Africa: a cohort study. PLosMedicine. February 9, 2010.10.1371/journal.pmed.1000229Search in Google Scholar

6. Warakamin S, Boonthai N, Tangcharoensathien V. Induced abortion in Thailand: current situation in public hospitals and legal perspectives. Reprod Health Matters. 2004; 12 (Suppl):147-56.10.1016/S0968-8080(04)24018-6Open DOISearch in Google Scholar

7. Ananworanich J, Bernard H. Intermittent therapy for the treatment of chronic HIV infection. AIDS. 2007; 21:123-34.10.1097/01.aids.0000256414.91105.8e17197802Open DOISearch in Google Scholar

8. Aidsmap news. http://www.aidsmap.com/en/news/4E9D555B-18FB-4D56-B912-2C28AFCCD36B.asp.Search in Google Scholar

9. Vernazza P, Hirschel B, Flepp M. Les personnes séropositives ne souffrant d’aucune autre MST et suivant un traitment antirtroviral efficace ne transmettent pas le VIH par voie sexuelle (in French). Bulletin Medecins Suisses. 2008; 89:165-69.10.4414/bms.2008.13252Search in Google Scholar

10. Shine AK. Catching up on contraception. Aust Fam Physician. 2009; 38:380-2.Search in Google Scholar

11. Feldblum PJ, Nasution MD, Hoke TH, Van Damme K, Turner AN, Gmach R, et al. Pregnancy among sex workers participating in a condom intervention trial highlights the need for dual protection. Contraception. 2007; 76:105-10.10.1016/j.contraception.2007.04.00917656179Search in Google Scholar

12. British HIV Association. UK Guidelines for the management of sexual and reproductive health of people living with HIV infection. 2008. Available at: www.bhiva.org.Search in Google Scholar

13. Thailand DHS, 1987, 1997. Thailand Reproductive Health Profile 2003 (unpublished). Available at: www.searo.who.int/LinkFiles/Family_Planning_Fact_Sheets_thailand.pdfSearch in Google Scholar

14. Heikinheimo O, Lähteenmäki P. Contraception and HIV infection in women. Hum Reprod Update. 2009; 15:165-76.10.1093/humupd/dmn049263908518978360Search in Google Scholar

15. Laher F, Todd CS, Stibich MA, Phofa R, Behane X, Mohapi L, et al. A qualitative assessment of decisions affecting contraceptive utilization and fertility intentions among HIV-positive women in Soweto, South Africa. AIDS Behav. 2009;13(Suppl 1):47-54.10.1007/s10461-009-9544-z19308719Search in Google Scholar

16. Asboe D, Catalan J, Mandalia S, Dedes N, Florence E, Schrooten W, et al. Sexual dysfunction in HIVpositive men is multi-factorial: A study of prevalence and associated factors. AIDS Care. 2007; 19:955 -65.10.1080/0954012070120984717851990Open DOISearch in Google Scholar

17. Moreno-Perez O, Escoin C, Serna-Candel C, Arias N, Alfayate R, Boix V, et al. Erectile dysfunction among HIV-infected men is associated with protease inhibitor containing HAART. Presented at International Conference in Endocrinology, Istanbul, April, 2009.Search in Google Scholar

18. Lara DK, Grossman DA, Muñoz JE, Rosario SR, Gómez BJ, García SG. Acceptability and use of the female condom and diaphragm among sex workers in Dominican Republic: results from a prospective study. AIDS Educ Prev. 2009; 21:538-51.10.1521/aeap.2009.21.6.538Open DOISearch in Google Scholar

19. Mekonnen T, Robays J, Negassa H, Fiesha G, Yadeta M, Bekele Y, et al. Acceptability of female condom among women involved in prostitution in Addis Ababa, Ethiopia. Presented at Intern Conf AIDS. July, 2002. (Abstract no. MoPeF3865Search in Google Scholar

20. Global Campaign for Microbicides. Methods for Improving Reproductive Health in Africa (MIRA). http://www.global-campaign.org/MIRA.htmSearch in Google Scholar

21. Ngubane N, Patel D, Newell ML, Coovadia HM, Rollins N, Coutsoudis A, et al. Messages about dual contraception in areas of high HIV prevalence are not heeded. S Afr Med J.2008; 98:209-12.Search in Google Scholar

22. Mallet J, Kalambi V. Coerced and forced sterilization of HIV-positive women in Namibia. HIV AIDS Policy Law Rev. 2008; 13:77-8.Search in Google Scholar

23. Practice Committee of the American Society for Reproductive Medicine. Hormonal contraception: recent advances and controversies. 2008 Search in Google Scholar

24. Stringer EM, Levy J, Sinkala M, Chi BH, Matongo I, Chintu N, Stringer JS. HIV disease progression by hormonal contraceptive method: secondary analysis of a randomized trial. AIDS. 2009: 23;1377-82.10.1097/QAD.0b013e32832cbca8Open DOISearch in Google Scholar

25. Stringer EM, Giganti M, Carter RJ, El-Sadr W, Abrams EJ, Stringer JS. MTCT-Plus InitiativeHormonal contraception and HIV disease progression: a multicountry cohort analysis of the MTCT-plus initiative. AIDS. 2009; 23 (Suppl 1):S69-77.10.1097/01.aids.0000363779.65827.e0Search in Google Scholar

26. Frölich M, Burhenne J, Martin-Facklam M, Weiss J, von Wolff M, Strowitzki T, et al. Oral contraception does not alter single dose saquinavir pharmacokinetics in women. Br J Clin Pharmacol. 2004; 57: 244-52.10.1111/j.1365-2125.2003.01983.xOpen DOISearch in Google Scholar

27. Schöller-Gyüre M, Kakuda TN, Woodfall B, Aharchi F, Peeters M, Vandermeulen K, et al. Effect of steadystate etravirine on the pharmacokinetics and pharmacodynamics of ethinylestradiol and norethindrone. Contraception. 2009; 80:44-52.10.1016/j.contraception.2009.01.009Open DOISearch in Google Scholar

28. Nanda K, Amaral E, Hays M, Viscola MA, Mehta N, Bahamondes L. Pharmacokinetic interactions between depot medroxyprogesterone acetate and combination antiretroviral therapy. Fertil Steril. 2008; 90:965-71.10.1016/j.fertnstert.2007.07.1348Open DOISearch in Google Scholar

29. Watts DH, Park JG, Cohn SE, Yu S, Hitti J, Stek A, et al. Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy ACTG A5093. Contraception. 2008; 77:84-90.10.1016/j.contraception.2007.10.002Search in Google Scholar

30. Panel on Antiretroviral guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. December 1, 2009; 1-161. Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.Search in Google Scholar

31. Womack J, Richman S, Tien PC, Grey M, Williams A. Hormonal contraception and HIV-positive women: metabolic concerns and management strategies. J Midwifery Womens Health. 2008; 53:362-75.10.1016/j.jmwh.2008.01.006Search in Google Scholar

32. Charonis G, Larsson PG. Prolonged use of intrauterine contraceptive device as a risk factor for tubo-ovarian abscess. Acta Obstet Gynecol Scand. 2009; 88:680-4.10.1080/00016340902893678Open DOISearch in Google Scholar

33. Hodoglugil NN, Aslan D, Bertan M. Intrauterine device use and some issues related to sexually transmitted disease screening and occurrence. Contraception. 2000; 61:359-64.10.1016/S0010-7824(00)00118-9Open DOISearch in Google Scholar

34. Joesoef MR, Karundeng A, Runtupalit C, Moran JS, Lewis JS, Ryan CA. High rate of bacterial vaginosis among women with intrauterine devices in Manado, Indonesia. Contraception. 2001; 64:169-72.10.1016/S0010-7824(01)00246-3Open DOISearch in Google Scholar

35. Stringer EM, Kaseba C, Levy J, Sinkala M, Goldenberg RL, Chi BH, et al. A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. Am J Obstet Gynecol. 2007; 197: 144.e1-8.10.1016/j.ajog.2007.03.031273075417689627Search in Google Scholar

36. WHO policy on microbicides. www.who.intSearch in Google Scholar

37. D’Cruz OJ, Uckun FM. Clinical development of microbicides for the prevention of HIV infection.- Curr Pharm Des. 2004; 10:315-36.10.2174/138161204338637414754390Search in Google Scholar

38. Batár I. State-of-the-art of non-hormonal methods of contraception: II. Chemical barrier contraceptives. Eur J Contracept Reprod Health Care. 2010; 15:89-95.10.3109/1362518090346232620055729Search in Google Scholar

39. Karim SA, Coletti A, Richardson B, Ramjee G, Hoffman I, Chirenje M, et al. Safety and effectiveness of vaginal microbicides bufferGel and 0.5% PRO 2000/5 gel for the prevention of HIV infection in women: results of the HPTN 035 trial [Abstract 48LB]. Presented at 16th Conference on Retroviruses and Opportunistic Infections. February 8-11, 2009, Montreal.Search in Google Scholar

40. Microbicides Development Programme. http://www.mdp.mrc.ac.uk/Search in Google Scholar

41. Microbicides Trials Network, MTN-002, www.mtnstopshiv.org.Search in Google Scholar